Cell Culture Market Poised to Achieve Significant Growth in the Years to Come
The technique of
growing cells outside the human body itself is a significant
advancement in scientific research. Cell
culture technique has been around since mid-20th century and
the field is continuously expanding into various areas of
pharmaceutical research and development such as cancer and
immunotherapy. Endeavor to improve the drug bioavailability and
therapeutic efficacy has led to better research outcomes in cancer
and health screening techniques. The ability to develop continuous
cell lines has enabled mass production of desired organ cells for
research and treatment benefits. Cell culture offers an excellent
model system for studying the normal physiology and biochemistry,
drug effects and drug screening. Being an exploratory research field,
use of reagents, instruments and other consumables is very critical
to support its advancements.
High Investment
in research and development by biotechnological companies
Players in the
global cell culture market are making major investments in R&D to
introduce advanced products used in the cell culture process owing to
rise in number of application and better return on investment.
Furthermore, companies are inclined towards novel product
development. For instance, Biovest International, in 2009, has
developed a product named AutovaxID-C, which is expected to reshape
the biologic production made in the industry. The product favors the
automated cell growth by replacing conventional cell growth chambers
that use to acquire a large space in the laboratory. Various other
factors such as increasing prevalence of chronic diseases, high
importance of tissue or organ replacement with cell culture process,
and increasing demand for antibody production are in turn projected
to fuel cell culture market growth. Also, rise in prevalence of
age-related macular degeneration is expected to underpin the cell
culture market growth. Eye conditions such as diabetic retinopathy in
tune with rise in number of diabetic patients globally in turn
creates a conducive environment for growth of the cell culture
market. AMD ranks third with a prevalence of around 8.7% globally in
2015, according to W.H.O.
Market Dynamics
Increasing research
on personalized therapies and stem cells is driving growth of the
market for cell culture. Also, growing organ transplantation and
biobanking of cells tissues and organs is driving growth of the
market for cell culture instruments and consumables. According to the
Global Observatory on Donation and Transplantation (GODT), around
119,873 organs were transplanted worldwide in 2014 (1.81% increase
over 2013). The demand-supply gap of organ transplantation is a major
problem faced globally. In the U.S. alone, nearly 118,652 patients
are waiting for organ transplant (U.S. Department of Health &
Human Service, 2017). Using cell culture technique to differentiate
cells of liver, heart and nervous system would aid in the treatment
of millions of such patients globally. Further, advent of 3D cell
culture technique has enabled researchers to understand the body
physiology and biological systems much better. Moreover, the spheroid
formation and scaffold-based techniques are driving demand for 3D
cell culture products.
Inquire Here
Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/116
Market Taxonomy
This report segments
the global cell culture market on the basis of products,
applications, end user, and geography. On the basis of product type,
the market is segmented into consumables and instruments. The
consumables market is categorized into media, sera, and reagents. The
instruments market is categorized into culture systems, incubators,
pipette, roller bottles, cryostorage equipment and biosafety
cabinets. The end users segment comprises academic and research
institutes and commercial pharma and biotech product manufacturers.
For comprehensive understanding of market dynamics, the global cell
culture market is analyzed across key geographical regions namely
North America, Europe, Asia Pacific, Latin America, Africa, and
Middle East. Each of these regions is analyzed on basis of market
findings across major countries in these regions for a macro-level
understanding of the market.
Key companies
covered as a part of this study include Thermo Fisher Scientific,
Inc., GE Healthcare, Corning, Inc., Sigma - Aldrich Corporation, VWR
International, LLC, Merck KGAA, Becton, Dickinson and Company,
Eppendorf AG, Sartorius AG and Lonza Group AG
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Comments
Post a Comment